Anacura acquires spin-off from Ghent University

Anacura adding multi-omics for drug discovery and diagnostics to its services

16-Jul-2024
© Anthony Van Driessche

Gerben Menschaert and Griet Nuytinck

Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a Ghent University spin-off specialized in advanced -omics technology.  The acquisition expands the existing anacura group activities at AnaBioTec and Labo Nuytinck towards drug discovery and diagnostics research.

Anacura CEO Griet Nuytinck says: “The acquisition of OHMX.bio is the next step in anacura’s aim to remain a frontrunner in innovative healthcare services, complementing ongoing initiatives within our existing business units. With the acquisition, we bring in a company with deep scientific expertise that shares our key values, enabling us to provide an even stronger service offering to the biotech community in Belgium and beyond.”

Established in 2019 as a Ghent University spin-off, OHMX.bio operates as a premier study design company, specializing in cutting-edge -omics technologies for discovery and (pre)clinical studies. The company combines multi-omic technologies, such as next-generation sequencing, in combination with advanced bio-informatics to speed up the discovery process and quality control of biologics and advanced therapy medicinal products (ATMPs) such asmRNA vaccines and CAR-T cells.

OHMX.bio CEO/CSO Gerben Menschaert adds: “Our activities complement the current service offering within the anacura group and, importantly, we share the same values, mission and drive for quality, scientific excellence, and a tailored personal approach.”

Menschaert is one of the co-founders of OHMX.bio and is a professor at the Lab of Bioinformatics and Computational Genomics at Ghent University.

“OHMX.bio joining the anacura family is a future proof move for both parties,” he says, “It will allow OHMX.bio to expand its portfolio and tap into new markets, Additionally, it strengthens anacura’s offering of innovative technologies. Collectively, we solidify anacura’s position as a one-stop shop for clients and market leader in the Ghent Biotech ecosystem.”

 

Other news from the department business & finance

Most read news

More news from our other portals

All mass spectrometers manufacturers at a glance

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.